Committee for Clinical Research and Medicines Strategy
ACC formed the Clinical Research and Drug Strategies Committee to define a strategy to promote Italian clinical and translational research.
-
Coordinator
Paolo Pronzato
IRCCS OSPEDALE POLICLINICO SAN MARTINO
-
Coordinator
Sandro Pignata
IRCCS FONDAZIONE PASCALE NAPOLI
The Committee aims to develop, in agreement with the relevant institutions and pharmaceutical companies, national and international clinical research strategies and projects in which ACC members can have a prominent role. It also aims to develop, with AIFA and Big Pharma, shared strategies to realize multicenter investigational clinical trials and Real-World Clinical Trials.
The Committee has also set up two working groups, Infrastructure Group and AIFA Group, which will operate in a more focused manner in their respective expertise areas.
Members
-
HSR MILANO
Bianchini Giampaolo
-
ISS ROMA
Biffoni Mauro
-
IEO MILANO
Curigliano Giuseppe
-
IOV PADOVA
De Salvo Gian Luca
-
IST GENOVA
Del Mastro Lucia
-
IRST MELDOLA
Delmonte Angelo
-
GASLINI GENOVA
Dufour Carlo
-
BESTA MILANO
Eoli Marica
-
CRO AVIANO
Fratino Lucia
-
GASLINI GENOVA
Garaventa Alberto
-
IRE ROMA
Giannarelli Diana
-
AIMAC
Iannelli Elisabetta
-
OPBG ROMA
Locatelli Franco
-
ISG BOLOGNA
Marchesi Emanuela
-
MONDINO PAVIA
Marchioni Enrico
-
IRCCS CANDIOLO
Montemurro Filippo
-
IRST MELDOLA
Nanni Oriana
-
IOR BOLOGNA
Palmerini Emanuela
-
OPBG ROMA
Quintarelli Concetta
-
INT BARI
Silvestris Nicola
-
CRO AVIANO
Toffoli Giuseppe
-
GEMELLI ROMA
Tortora Giampaolo
-
ICH ROZZANO
Zucali Paolo